XOMA (STU:X0M1) Additional Paid-In Capital : €1,208.91 Mil(As of Mar. 2024)

View and export this data going back to 1986. Start your Free Trial

What is XOMA Additional Paid-In Capital?

XOMA's quarterly additional paid-in capital declined from Sep. 2023 (€1,226.48 Mil) to Dec. 2023 (€1,202.93 Mil) but then increased from Dec. 2023 (€1,202.93 Mil) to Mar. 2024 (€1,208.91 Mil).

XOMA's annual additional paid-in capital increased from Dec. 2021 (€1,156.72 Mil) to Dec. 2022 (€1,233.12 Mil) but then declined from Dec. 2022 (€1,233.12 Mil) to Dec. 2023 (€1,202.93 Mil).

XOMA Additional Paid-In Capital Historical Data

The historical data trend for XOMA's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XOMA Additional Paid-In Capital Chart

XOMA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

1,114.47

1,041.78

1,156.72

1,233.12

1,202.93

XOMA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															1,220.36	1,206.91	1,226.48	1,202.93	1,208.91

XOMA Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

XOMA Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of XOMA's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

XOMA (STU:X0M1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Corp (STU:X0M1) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

XOMAO.PFD:USA XOMAP.PFD:USA XOMA:USA X0M1:Germany

Address

2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608

Website

https://www.xoma.com

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

XOMA (STU:X0M1) Headlines

No Headlines